Business · 04/11/2010Updated: 10/17/2026 · 1 min read
FDA Reopens Comment Period for Generic Drug User Fee Program
Summary
The FDA is extending the public comment period for the generic drug user fee program until December 6, 2010, to allow for consideration of late-received comments and provide an opportunity for stakeholders to share their views on the matter.
Original source language: Federal Register — Health and Human ServicesOpen original release →